1. Home
  2. GNLX vs CHN Comparison

GNLX vs CHN Comparison

Compare GNLX & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • CHN
  • Stock Information
  • Founded
  • GNLX 2001
  • CHN 1992
  • Country
  • GNLX United States
  • CHN United States
  • Employees
  • GNLX N/A
  • CHN N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • CHN Investment Managers
  • Sector
  • GNLX Health Care
  • CHN Finance
  • Exchange
  • GNLX Nasdaq
  • CHN Nasdaq
  • Market Cap
  • GNLX 129.9M
  • CHN 153.9M
  • IPO Year
  • GNLX 2023
  • CHN N/A
  • Fundamental
  • Price
  • GNLX $3.53
  • CHN $15.84
  • Analyst Decision
  • GNLX Strong Buy
  • CHN
  • Analyst Count
  • GNLX 5
  • CHN 0
  • Target Price
  • GNLX $16.20
  • CHN N/A
  • AVG Volume (30 Days)
  • GNLX 153.8K
  • CHN 31.8K
  • Earning Date
  • GNLX 08-13-2025
  • CHN 01-01-0001
  • Dividend Yield
  • GNLX N/A
  • CHN 0.19%
  • EPS Growth
  • GNLX N/A
  • CHN N/A
  • EPS
  • GNLX N/A
  • CHN N/A
  • Revenue
  • GNLX N/A
  • CHN N/A
  • Revenue This Year
  • GNLX N/A
  • CHN N/A
  • Revenue Next Year
  • GNLX N/A
  • CHN N/A
  • P/E Ratio
  • GNLX N/A
  • CHN N/A
  • Revenue Growth
  • GNLX N/A
  • CHN N/A
  • 52 Week Low
  • GNLX $1.60
  • CHN $9.00
  • 52 Week High
  • GNLX $5.89
  • CHN $12.98
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 58.36
  • CHN 72.84
  • Support Level
  • GNLX $3.30
  • CHN $15.75
  • Resistance Level
  • GNLX $3.60
  • CHN $16.41
  • Average True Range (ATR)
  • GNLX 0.26
  • CHN 0.22
  • MACD
  • GNLX 0.00
  • CHN -0.02
  • Stochastic Oscillator
  • GNLX 75.71
  • CHN 63.23

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About CHN China Fund Inc. (The)

CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.

Share on Social Networks: